![](https://www.e-med.co.il/wp-content/uploads/2022/06/default-312x200.jpg)
Perspective on OIG Guidelines for Pharmaceutical Companies: An Expert Interview With Arthur Palamara, MD
Laurie Barclay, MD Oct. 9, 2002 Editor’s Note: The Office of the Inspector General (OIG) is
Laurie Barclay, MD Oct. 9, 2002 Editor’s Note: The Office of the Inspector General (OIG) is
Laurie Barclay, MD Oct. 9, 2002 — Two new molecular markers of type II collagen metabolism help
A research letter in The Lancet suggests that users of high-dose rofecoxib were 1·7 times more likely
Opioid analgesics (opioids), powerful pain relievers whose use has been hotly debated in the medical community, should
Patients who undergo hip arthroplasty and continue warfarin therapy after hospital discharge are less likely to experience
The formulation of some calcium carbonate supplements significantly interferes with calcium absorption and patients may thus be
Clodronate, 1600 mg/d given orally for two years, significantly decreased the rate of bone metastases by 56
Post-menopausal women who perform back strengthening exercises to reduce the risk of vertebral fractures can continue to
Patients with chronic obstructive pulmonary disease (COPD) and a low body mass index (BMI) have an increase
A modest weight training program done twice a week helps improve bone mineral density (BMD) in older
נא ציין כתובת דואר אלקטרוני שבה אתה מקבל דיוורי e-Med או זו שציינת בכרטיס האישי שלך.
קישור לאיפוס סיסמא נשלח למייל.
חזרה להתחברות